Department of Psychiatry and Psychotherapy, University of Leipzig, Leipzig, Germany.
Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University of Leipzig, Leipzig, Germany.
Psychoneuroendocrinology. 2022 Jun;140:105728. doi: 10.1016/j.psyneuen.2022.105728. Epub 2022 Mar 14.
The orexigenic hormone ghrelin is being increasingly recognized as a stress hormone being involved in anxiety regulation. In animals, ghrelin effects on, and responses to acute stress differed from those in chronic stress, an animal model for anxiety and depression. In humans, elevated ghrelin levels were reported in pathological anxiety (e.g. panic disorder). However, no reports exist on physiological anxiety in mentally healthy subjects. In addition, reports on generalized anxiety symptoms, both in mentally healthy subjects (e.g. worrying) or in adult patients, are lacking. Total serum ghrelin was determined in 1666 subjects of a population-based cross-sectional study ('LIFE'). The 7-item Generalized Anxiety Disorder Scale (GAD-7), detecting also other anxiety disorders, was administered. For multiple linear regression analyses, 1091 subjects were finally included. Serum ghrelin and GAD-7 scores were positively but not significantly associated in the total group (ß=0.00025, standardized β = 0.039, 95%CI: -0.00006;0.0006;p = 0.144), in subjects with no more than mild anxiety, there was a significant positive association (GAD-7 ≤9: n = 1061, 97.25%, β = 0.00032; standardized β = 0.060; 95%CI: 0.000023;0.00062;p = 0.036). In contrast, there was a negative association in subjects with anxiety symptoms above the GAD-7 cut-off (GAD-7 ≥10: n = 30, 2.75%, ß=-0.003, standardized β = -0.462; 95% CI:-0.006;0.0001;p = 0.045). Ghrelin levels were only numerically (p = 0.23) higher in subjects with clinically relevant anxiety symptoms (963.5 ± 399.6 pg/ml; mean±SD) than in those without (901.0 ± 416.4 pg/ml). In conclusion, the positive association between ghrelin and no more than mild anxiety is an initial indication for a role for ghrelin in the regulation of physiological anxiety in humans. This association and the opposed association in pathological anxiety resemble findings in animals showing diverging ghrelin effects in acute and chronic stress.
促食欲激素胃饥饿素(Ghrelin) 作为一种应激激素,其在焦虑调节中的作用正日益受到重视。在动物中,Ghrelin 对急性应激和慢性应激的作用和反应不同,而慢性应激是焦虑和抑郁的动物模型。在人类中,病理性焦虑(如惊恐障碍)患者的 Ghrelin 水平升高。然而,在心理健康的受试者中,尚无关于生理性焦虑的报道。此外,在心理健康的受试者(如担忧)或成年患者中,也缺乏关于广泛性焦虑症状的报道。在一项基于人群的横断面研究(“LIFE”)中,测定了 1666 名受试者的总血清 Ghrelin 水平。同时还使用了 7 项广泛性焦虑障碍量表(GAD-7),该量表可检测到其他焦虑障碍。对于多元线性回归分析,最终纳入了 1091 名受试者。在总人群中,血清 Ghrelin 和 GAD-7 评分呈正相关,但无统计学意义(β=0.00025,标准化β=0.039,95%CI:-0.00006;0.0006;p=0.144),在焦虑程度不超过轻度的受试者中,两者存在显著正相关(GAD-7≤9:n=1061,97.25%,β=0.00032;标准化β=0.060;95%CI:0.000023;0.00062;p=0.036)。相比之下,在焦虑症状超过 GAD-7 临界值的受试者中,两者呈负相关(GAD-7≥10:n=30,2.75%,β=-0.003,标准化β=-0.462;95%CI:-0.006;0.0001;p=0.045)。有临床相关焦虑症状的受试者的 Ghrelin 水平仅略高(p=0.23)(963.5±399.6pg/ml;均值±标准差),而无焦虑症状的受试者为 901.0±416.4pg/ml。总之,Ghrelin 与不超过轻度焦虑之间的正相关是 Ghrelin 在人类生理性焦虑调节中发挥作用的初步迹象。这种相关性和病理性焦虑中的相反相关性类似于动物研究中的发现,即 Ghrelin 在急性和慢性应激中的作用不同。